Ramsay Generale denteFRA:GD6 -0.44%71 PS Ratio is 0.46 as of Jul. 02, 2026, which is 10% above its 10-year median of 0.42. GuruFocus rates FRA:GD6 with a GF Score™ of 71/100 and a GF Value™ of €21.72. The stock has 8 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Ramsay Generale dente ranks better than 81.94% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Ramsay Generale dente's share price is €11.20.
Ramsay Generale dente's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €24.20. Hence, Ramsay Generale dente's PS Ratio for today is 0.46.
The historical rank and industry rank for Ramsay Generale dente's PS Ratio or its related term are showing as below:
FRA:GD6'
s PS Ratio Range Over the Past 10 Years
Min: 0.36 Med: 0.42 Max: 0.89
Current: 0.47
During the past 13 years, Ramsay Generale dente's highest PS Ratio was 0.89. The lowest was 0.36. And the median was 0.42.
FRA:GD6's PS Ratio is ranked better than 81.94% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.5
vs FRA:GD6: 0.47
Ramsay Generale de Sante SA revenue growth has slowed down over the past 12 months.
During the past 3 years, the average Revenue per Share Growth Rate was 6.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 6.00% per year.
During the past 13 years, Ramsay Generale dente's highest 3-Year average Revenue per Share Growth Rate was 13.90% per year. The lowest was -5.00% per year. And the median was 0.70% per year.
Back to Basics: PS Ratio
Ramsay Generale dente (FRA:GD6) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ramsay Generale dente's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramsay Generale dente PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Generale dente's PS Ratio distribution charts can be found below:
* The bar in red indicates where Ramsay Generale dente's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Ramsay Generale dente's Share Price of today is €11.20. Ramsay Generale dente's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €24.20.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Ramsay Generale dente (FRA:GD6) has a PS Ratio of 0.46 as of Jul. 02, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Ramsay Generale dente and its competitors. This is 10% above median its historical median of 0.42. Over the past decade, Ramsay Generale dente's PS Ratio has ranged from 0.36 to 0.89. According to the industry distribution chart, Ramsay Generale dente ranks #119 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 18.1%.
Is Ramsay Generale dente's PS Ratio too high?
Ramsay Generale dente's current PS Ratio of 0.46 is 10% above median its 10-year median of 0.42. Over the past 10 years, this metric has ranged from a low of 0.36 to a high of 0.89. The Healthcare Providers & Services industry median PS Ratio is 1.50. Ramsay Generale dente's value of 0.46 is 69.3% below this industry median. Based on the distribution chart, Ramsay Generale dente ranks #119 out of 659 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ramsay Generale dente has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Ramsay Generale dente's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Generale dente ranks #119 out of 659 companies for PS Ratio. This places Ramsay Generale dente in the top 18% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.50. Ramsay Generale dente's value of 0.46 is 69.3% below this benchmark. Historically, Ramsay Generale dente's own PS Ratio has ranged from 0.36 to 0.89 over the past decade. While the company's 10-year median is 0.42 vs. the industry median of 1.50, Ramsay Generale dente has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.50, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramsay Generale dente's current PS Ratio of 0.46 is 69.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Ramsay Generale dente and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Generale dente's current PS Ratio is 0.46, which is 10% above median its own 10-year median of 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Generale dente stock overvalued right now?
Ramsay Generale dente (FRA:GD6) has a current PS Ratio of 0.46. The stock's GF Value™ is €21.72, compared to a current price of €11.20 — trading 48.4% below its estimated fair value. The current PS Ratio is 0.46, which is 10% above median its 10-year median of 0.42 and 69.3% below the Healthcare Providers & Services industry median of 1.50. Ramsay Generale dente's overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Ramsay Generale dente (FRA:GD6), the current PS Ratio is 0.46 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Generale dente (FRA:GD6) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Generale dente stock appears to be undervalued.
The current stock price of €11.20 is trading 48.4% below its estimated GF Value™ of €21.72.
Key valuation signals for FRA:GD6:
PS Ratio: 0.46 (10% above median its 10-year median of 0.42)
GF Value™: €21.72 vs. price of €11.20 (48.4% below fair value)
Industry Position: 69.3% below the Healthcare Providers & Services median (#119 of 659)
No single metric tells the full story. See the FRA:GD6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.
71GF Score
Get the complete analysis for FRA:GD6
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:GD6 has been successfully added to your 
